4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-19-016572
Options or other derivatives
- Director acquired 29,387 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Saad Mark E Director | 2019-03-19 | Grant or award · Stock Option (Right to Buy) | +29,387 | 29,387 | D | ||
Loading xslF345X03/a4.xml…